İnotropik ve Vazopressör Ajanlar

Vincent J-L, De Backer D, editors. Inotrope/vasopressor support in sepsis-induced organ hypoperfusion. Seminars in respiratory and critical care medicine; 2001: Copyright© 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New ….

Stanchina ML, Levy MM, editors. Vasoactive drug use in septic shock. Seminars in respiratory and critical care medicine; 2004: Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New ….

Ahlquist RP. A study of the adrenotropic receptors. American Journal of Physiology-Legacy Content. 1948;153(3):586-600.

Allwood M, Cobbold A, Ginsburg J. Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine. British Medical Bulletin. 1963;19(2):132-6.

Tabaee A, Givertz M. Pharmacologic management of the hypotensive patient. Irwin and Rippe's Intensive Care Medicine, 5th Ed, edited by Irwin RS, Rippe JM, Philadelphia, Lippincott Williams & Wilkins. 2003:295-302.

Holmes CL. Vasoactive drugs in the intensive care unit. Current opinion in critical care. 2005;11(5):413-7.

Träger K, DeBacker D, Radermacher P. Metabolic alterations in sepsis and vasoactive drug–related metabolic effects. Current opinion in critical care. 2003;9(4):271-8.

Bellomo R. Noradrenaline: friend or foe? Heart, Lung and Circulation. 2003;12:S42-S8.

Treggiari MM, Romand J-A, Burgener D, Suter PM, Aneman A. Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock. Critical care medicine. 2002;30(6):1334-9.

Bracco D, Parlow JL. Best evidence in anesthetic practice Prevention: dopamine does not prevent death, acute renal failure, or need for dialysis. Canadian Journal of Anesthesia/Journal canadien d'anesthésie. 2002;49(4):417-9.

Marik P. Low-dose dopamine: a systematic review. Intensive care medicine. 2002;28(7):877-83.

Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Critical care medicine. 2004;32(9):1928-48.

Asfar P, De Backer D, Meier-Hellmann A, Radermacher P, Sakka SG. Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Critical care. 2003;8(3):170.

Rivers E, Nguyen B. Havs tad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group: Early goaldirected therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-77.

Rauch H, Motsch J, Böttiger BW. Newer approaches to the pharmacological management of heart failure. Current Opinion in Anesthesiology. 2006;19(1):75-81.

Bilkovski RN, Rivers EP, Horst HM. Targeted resuscitation strategies after injury. Current opinion in critical care. 2004;10(6):529-38.

Gutierrez G, Reines H, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Critical care. 2004;8(5):373.

Dellinger RP. Cardiovascular management of septic shock. Critical care medicine. 2003;31(3):946-55.

Heinrichs J, Fritze Z, Klassen T, Curtis S. A systematic review and meta-analysis of new interventions for peripheral intravenous cannulation of children. Pediatric Emergency Care. 2013;29(7):858-66.